Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Energy balance in obese, mechanically ventilated intensive care unit patients.

Vest MT, Newell E, Shapero M, McGraw P, Jurkovitz C, Lennon SL, Trabulsi J.

Nutrition. 2019 Apr 26;66:48-53. doi: 10.1016/j.nut.2019.02.021. [Epub ahead of print]

2.

Telephone-Based Shared Decision-making for Lung Cancer Screening in Primary Care.

Fagan HB, Fournakis NA, Jurkovitz C, Petrich AM, Zhang Z, Katurakes N, Myers RE.

J Cancer Educ. 2019 May 9. doi: 10.1007/s13187-019-01528-z. [Epub ahead of print]

PMID:
31069714
3.

Chronic Kidney Disease stratification using office visit records: Handling data imbalance via hierarchical meta-classification.

Bhattacharya M, Jurkovitz C, Shatkay H.

BMC Med Inform Decis Mak. 2018 Dec 12;18(Suppl 4):125. doi: 10.1186/s12911-018-0675-x.

4.

Evaluation of a Systems-Based Tobacco Cessation Program Using Bedside Volunteers.

Taylor D, Medaglio D, Jurkovitz C, Patterson F, Zhang Z, Gbadebo A, Bradley E, Wessells R, Goldenberg E.

Nicotine Tob Res. 2018 Nov 21. doi: 10.1093/ntr/nty252. [Epub ahead of print]

PMID:
30462274
5.

Co-occurrence of medical conditions: Exposing patterns through probabilistic topic modeling of snomed codes.

Bhattacharya M, Jurkovitz C, Shatkay H.

J Biomed Inform. 2018 Jun;82:31-40. doi: 10.1016/j.jbi.2018.04.008. Epub 2018 Apr 12.

6.

Association Between Enteral Feeding, Weight Status, and Mortality in a Medical Intensive Care Unit.

Vest MT, Kolm P, Bowen J, Trabulsi J, Lennon SL, Shapero M, McGraw P, Halbert J, Jurkovitz C.

Am J Crit Care. 2018 Mar;27(2):136-143. doi: 10.4037/ajcc2018598.

7.

Characteristics and Outcomes of Adult Inpatients With Malnutrition.

Vest MT, Papas MA, Shapero M, McGraw P, Capizzi A, Jurkovitz C.

JPEN J Parenter Enteral Nutr. 2018 Aug;42(6):1009-1016. doi: 10.1002/jpen.1042. Epub 2017 Dec 27.

PMID:
29360158
8.

Patient Satisfaction with Care After Coronary Revascularization.

Mosby DL, Manierre MJ, Martin SS, Kolm P, Abuzaid AS, Jurkovitz CT, Elliott DJ, Weintraub WS.

Patient. 2018 Apr;11(2):217-223. doi: 10.1007/s40271-017-0274-4.

PMID:
28875457
9.

Dietary sodium and health: more than just blood pressure.

Farquhar WB, Edwards DG, Jurkovitz CT, Weintraub WS.

J Am Coll Cardiol. 2015 Mar 17;65(10):1042-50. doi: 10.1016/j.jacc.2014.12.039. Review.

10.

Cardiovascular implantable electronic devices in hemodialysis patients: prevalence and implications for arteriovenous hemodialysis access interventions.

Saad TF, Ahmed W, Davis K, Jurkovitz C.

Semin Dial. 2015 Jan-Feb;28(1):94-100. doi: 10.1111/sdi.12249. Epub 2014 May 27.

PMID:
24863543
11.

Risk factors for cardiovascular events and bleeding complications following non-cardiac surgery or procedure in patients with drug eluting stent placement.

Tiwari D, Jurkovitz CT, Zhang Z, Bowen J, Kolm P, Wygant G, Weintraub WS.

Heart Asia. 2014 May 22;6(1):69-75. doi: 10.1136/heartasia-2013-010471. eCollection 2014.

12.

Asymptomatic deep vein thrombosis in patients undergoing screening duplex ultrasonography.

Zubrow MT, Urie J, Jurkovitz C, Jiang X, Bowen JR, DiSabatino A, Weintraub W.

J Hosp Med. 2014 Jan;9(1):19-22. doi: 10.1002/jhm.2112. Epub 2013 Nov 29.

PMID:
24288353
13.

Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).

Sedlis SP, Jurkovitz CT, Hartigan PM, Kolm P, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, Boden WE, Weintraub WS; COURAGE Study Investigators.

Am J Cardiol. 2013 Dec 1;112(11):1703-8. doi: 10.1016/j.amjcard.2013.07.034. Epub 2013 Sep 3.

14.

The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program.

Memon I, Norris KC, Bomback AS, Peralta C, Li S, Chen SC, McCullough PA, Whaley-Connell A, Jurkovitz C, Tamura MK, Saab G; for the Kidney Early Evaluation Program Investigators.

Cardiorenal Med. 2013 Jul;3(2):120-127. Epub 2013 Jun 1.

15.

Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP).

Jurkovitz CT, Li S, Norris KC, Saab G, Bomback AS, Whaley-Connell AT, McCullough PA; KEEP Investigators.

Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S24-32. doi: 10.1053/j.ajkd.2012.12.015.

16.

Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report.

Whaley-Connell AT, Kurella Tamura M, Jurkovitz CT, Kosiborod M, McCullough PA.

Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S1-3. doi: 10.1053/j.ajkd.2013.01.006. No abstract available.

17.

Frequency of severe valvular disease caused by mediastinal radiation among patients undergoing valve surgery in a community-based, regional academic medical center.

Copeland KA, Hosmane VR, Jurkovitz C, Kolm P, Bowen J, DiSabatino A, Banbury MK, Strasser JF, Weintraub WS, Doorey AJ.

Clin Cardiol. 2013 Apr;36(4):217-21. doi: 10.1002/clc.22106. Epub 2013 Mar 14.

18.

Direct care nurses' knowledge in acute myocardial infarction treatment.

Eckman T, Haley R, Bradley E, Albert M, Kolm P, Jurkovitz C.

J Nurses Staff Dev. 2012 Sep-Oct;28(5):229-32.

PMID:
22992637
19.

Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participants.

Saab G, Chen SC, Li S, Bomback AS, Whaley-Connell AT, Jurkovitz CT, Norris KC, McCullough PA; KEEP Investigators.

Am J Kidney Dis. 2012 Mar;59(3 Suppl 2):S34-9. doi: 10.1053/j.ajkd.2011.11.020.

20.

Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP).

Jurkovitz CT, Elliott D, Li S, Saab G, Bomback AS, Norris KC, Chen SC, McCullough PA, Whaley-Connell AT; KEEP Investigators.

Am J Kidney Dis. 2012 Mar;59(3 Suppl 2):S24-33. doi: 10.1053/j.ajkd.2011.11.019.

21.

Determinants of excessive daytime sleepiness and fatigue in adults with heart failure.

Riegel B, Ratcliffe SJ, Sayers SL, Potashnik S, Buck HG, Jurkovitz C, Fontana S, Weaver TE, Weintraub WS, Goldberg LR.

Clin Nurs Res. 2012 Aug;21(3):271-93. doi: 10.1177/1054773811419842. Epub 2011 Aug 30.

22.

Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP).

Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Norris KC, Shlipak MG.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1858-65. doi: 10.2215/CJN.00500111. Epub 2011 Jul 22.

23.

Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program.

McCullough PA, Whaley-Connell A, Brown WW, Collins AJ, Chen SC, Li S, Norris KC, Jurkovitz C, McFarlane S, Obialo C, Sowers J, Stevens L, Vassalotti JA, Bakris GL; Kidney Early Evaluation Program (KEEP) Investigators.

Intern Med J. 2010 Dec;40(12):833-41. doi: 10.1111/j.1445-5994.2009.02158.x.

PMID:
21199222
24.

Prepregnancy body mass index as an independent risk factor for pregnancy-induced hypertension.

Ehrenthal DB, Jurkovitz C, Hoffman M, Jiang X, Weintraub WS.

J Womens Health (Larchmt). 2011 Jan;20(1):67-72. doi: 10.1089/jwh.2010.1970. Epub 2010 Dec 31.

PMID:
21194273
25.

Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).

Stevens LA, Li S, Wang C, Huang C, Becker BN, Bomback AS, Brown WW, Burrows NR, Jurkovitz CT, McFarlane SI, Norris KC, Shlipak M, Whaley-Connell AT, Chen SC, Bakris GL, McCullough PA.

Am J Kidney Dis. 2010 Mar;55(3 Suppl 2):S23-33. doi: 10.1053/j.ajkd.2009.09.035.

26.

Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP).

Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Narva AS, Norris KC, Shlipak MG.

Am J Kidney Dis. 2010 Mar;55(3 Suppl 2):S15-22. doi: 10.1053/j.ajkd.2009.09.034.

27.

Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.

Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, O'Rourke RA, Boden WE, Weintraub WS; COURAGE Study Investigators.

Am J Cardiol. 2009 Dec 15;104(12):1647-53. doi: 10.1016/j.amjcard.2009.07.043.

PMID:
19962469
28.

A study of perioperative hyperglycemia in patients with diabetes having colon, spine, and joint surgery.

Smith DK, Bowen J, Bucher L, Hawkins T, Jurkovitz C, Reed J 3rd, Volk S.

J Perianesth Nurs. 2009 Dec;24(6):362-9. doi: 10.1016/j.jopan.2009.10.011.

PMID:
19962103
29.
30.

The risk of cardiovascular events in primary care patients following an episode of severe hypertension.

Ewen E, Zhang Z, Kolm P, Jurkovitz C, Jackson J, Fidan D, Weintraub WS.

J Clin Hypertens (Greenwich). 2009 Apr;11(4):175-82. doi: 10.1111/j.1751-7176.2009.00097.x.

31.

Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention.

Ewen EF, Zhao L, Kolm P, Jurkovitz C, Fidan D, White HD, Gallo R, Weintraub WS.

J Interv Cardiol. 2009 Jun;22(3):266-73. doi: 10.1111/j.1540-8183.2009.00431.x. Epub 2009 Feb 26.

PMID:
19298500
32.

Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.

Rizk D, Jurkovitz C, Veledar E, Bagby S, Baumgarten DA, Rahbari-Oskoui F, Steinman T, Chapman AB.

Clin J Am Soc Nephrol. 2009 Mar;4(3):560-6. doi: 10.2215/CJN.02410508. Epub 2009 Mar 4.

33.

Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program.

Jolly SE, Li S, Chen SC, Narva AS, Jurkovitz CT, Norris KC, Shlipak MG.

Am J Nephrol. 2009;29(5):440-6. doi: 10.1159/000174857. Epub 2008 Nov 14.

34.

Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.

Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett PG; Department of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study Coordinators.

Circ Cardiovasc Qual Outcomes. 2008 Sep;1(1):12-20. doi: 10.1161/CIRCOUTCOMES.108.798462.

PMID:
20031783
35.

Effect of PCI on quality of life in patients with stable coronary disease.

Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE; COURAGE Trial Research Group, Mancini GB.

N Engl J Med. 2008 Aug 14;359(7):677-87. doi: 10.1056/NEJMoa072771.

36.

Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.

McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti J, Whaley-Connell AT, Brenner RM, Bakris GL; KEEP Investigators.

Am Heart J. 2008 Aug;156(2):277-83. doi: 10.1016/j.ahj.2008.02.024. Epub 2008 Jun 4. Erratum in: Am Heart J. 2008 Dec;156(6):1132. Vassaloti, Joseph [corrected to Vassalotti, Joseph].

PMID:
18657657
37.

CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.

McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, Chen SC, Norris KC, McFarlane SI, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti JA, Whaley-Connell AT; Kidney Early Evaluation Program Investigators.

Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S38-45. doi: 10.1053/j.ajkd.2007.12.017.

PMID:
18359407
38.

The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population.

Jurkovitz CT, Qiu Y, Wang C, Gilbertson DT, Brown WW.

Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S3-12. doi: 10.1053/j.ajkd.2007.12.022.

PMID:
18359405
39.

Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).

Duru OK, Li S, Jurkovitz C, Bakris G, Brown W, Chen SC, Collins A, Klag M, McCullough PA, McGill J, Narva A, Pergola P, Singh A, Norris K.

Am J Kidney Dis. 2008 Feb;51(2):192-8. doi: 10.1053/j.ajkd.2007.09.023.

40.

Low birth weight is associated with chronic kidney disease only in men.

Li S, Chen SC, Shlipak M, Bakris G, McCullough PA, Sowers J, Stevens L, Jurkovitz C, McFarlane S, Norris K, Vassalotti J, Klag MJ, Brown WW, Narva A, Calhoun D, Johnson B, Obialo C, Whaley-Connell A, Becker B, Collins AJ; Kidney Early Evaluation Program Investigators.

Kidney Int. 2008 Mar;73(5):637-42. Epub 2007 Dec 19.

41.

A population study of the contribution of medical comorbidity to the risk of prematurity in blacks.

Ehrenthal DB, Jurkovitz C, Hoffman M, Kroelinger C, Weintraub W.

Am J Obstet Gynecol. 2007 Oct;197(4):409.e1-6.

PMID:
17904981
42.

Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).

McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL; KEEP Investigators.

Arch Intern Med. 2007 Jun 11;167(11):1122-9.

PMID:
17563019
43.

Comparison of recovery after mitral valve repair and replacement.

Zhao L, Kolm P, Borger MA, Zhang Z, Lewis C, Anderson G, Jurkovitz CT, Borkon AM, Lyles RH, Weintraub WS.

J Thorac Cardiovasc Surg. 2007 May;133(5):1257-63.

44.

Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trial.

Zhang Z, Foster JK, Kolm P, Jurkovitz CT, Parker KM, Murrah NV, Anderson GT, Douglas JS Jr, Weintraub WS.

Am Heart J. 2006 Oct;152(4):770-6.

PMID:
16996857
45.

Obesity is associated with family history of ESRD in incident dialysis patients.

Speckman RA, McClellan WM, Volkova NV, Jurkovitz CT, Satko SG, Schoolwerth AC, Freedman BI.

Am J Kidney Dis. 2006 Jul;48(1):50-8.

PMID:
16797386
46.

Anemia and cardiovascular and kidney disease.

Jurkovitz C, Abramson J, McClellan WM.

Curr Opin Nephrol Hypertens. 2006 Mar;15(2):117-22. Review.

PMID:
16481876
47.

The epidemiology and control of anaemia among pre-ESRD patients with chronic kidney disease.

McClellan WM, Jurkovitz C, Abramson J.

Eur J Clin Invest. 2005 Dec;35 Suppl 3:58-65. Review.

PMID:
16281960
48.

Coronary stent restenosis in patients treated with cilostazol.

Douglas JS Jr, Holmes DR Jr, Kereiakes DJ, Grines CL, Block E, Ghazzal ZM, Morris DC, Liberman H, Parker K, Jurkovitz C, Murrah N, Foster J, Hyde P, Mancini GB, Weintraub WS; Cilostazol for Restenosis Trial (CREST) Investigators.

Circulation. 2005 Nov 1;112(18):2826-32. Epub 2005 Oct 24.

PMID:
16246948
49.

Population-based screening for family history of end-stage renal disease among incident dialysis patients.

Freedman BI, Volkova NV, Satko SG, Krisher J, Jurkovitz C, Soucie JM, McClellan WM.

Am J Nephrol. 2005 Nov-Dec;25(6):529-35. Epub 2005 Sep 21.

PMID:
16179780
50.

Prevalence of family history of kidney disease and perception of risk for kidney disease: a population-based study.

Jurkovitz C, Hylton TN, McClellan WM.

Am J Kidney Dis. 2005 Jul;46(1):11-7.

PMID:
15983952

Supplemental Content

Loading ...
Support Center